Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Mycoplasma bovis delay in apoptosis of macrophages is accompanied by increased expression of anti-apoptotic genes, reduced cytochrome C translocation and inhibition of DNA fragmentation.

Maina T, Prysliak T, Perez-Casal J.

Vet Immunol Immunopathol. 2019 Feb;208:16-24. doi: 10.1016/j.vetimm.2018.12.004. Epub 2018 Dec 18.

PMID:
30712788
2.

The Performance of Three Immune Assays to Assess the Serological Status of Cattle Experimentally Exposed to Mycoplasma bovis.

Schibrowski ML, Barnes TS, Wawegama NK, Vance ME, Markham PF, Mansell PD, Marenda MS, Kanci A, Perez-Casal J, Browning GF, Gibson JS, Mahony TJ.

Vet Sci. 2018 Mar 8;5(1). pii: E27. doi: 10.3390/vetsci5010027.

3.

Th-17 cell mediated immune responses to Mycoplasma bovis proteins formulated with Montanide ISA61 VG and curdlan are not sufficient for protection against an experimental challenge with Mycoplasma bovis.

Prysliak T, Maina T, Perez-Casal J.

Vet Immunol Immunopathol. 2018 Mar;197:7-14. doi: 10.1016/j.vetimm.2018.01.004. Epub 2018 Jan 12.

PMID:
29475510
4.

Mycoplasma bovis-Induced Inhibition of Bovine Peripheral Blood Mononuclear Cell Proliferation Is Ameliorated after Blocking the Immune-Inhibitory Programmed Death 1 Receptor.

Suleman M, Cyprian FS, Jimbo S, Maina T, Prysliak T, Windeyer C, Perez-Casal J.

Infect Immun. 2018 Feb 20;86(3). pii: e00921-17. doi: 10.1128/IAI.00921-17. Print 2018 Mar.

5.

Induction of a balanced IgG1/IgG2 immune response to an experimental challenge with Mycoplasma bovis antigens following a vaccine composed of Emulsigen™, IDR peptide1002, and poly I:C.

Prysliak T, Maina T, Yu L, Suleman M, Jimbo S, Perez-Casal J.

Vaccine. 2017 Dec 4;35(48 Pt B):6604-6610. doi: 10.1016/j.vaccine.2017.10.037. Epub 2017 Oct 24.

PMID:
29079106
6.

Effect of Mycoplasma bovis on bovine neutrophils.

Jimbo S, Suleman M, Maina T, Prysliak T, Mulongo M, Perez-Casal J.

Vet Immunol Immunopathol. 2017 Jun;188:27-33. doi: 10.1016/j.vetimm.2017.04.011. Epub 2017 May 1.

PMID:
28615125
7.

A serologic survey of Mycoplasma spp. in farmed bison ( Bison bison) herds in western Canada.

Bras AL, Suleman M, Woodbury M, Register K, Barkema HW, Perez-Casal J, Windeyer MC.

J Vet Diagn Invest. 2017 Jul;29(4):513-521. doi: 10.1177/1040638717710057. Epub 2017 Jun 5.

PMID:
28578617
8.

Clinical presentation, prevalence, and risk factors associated with Mycoplasma bovis-associated disease in farmed bison (Bison bison) herds in western Canada.

Bras AL, Barkema HW, Woodbury MR, Ribble CS, Perez-Casal J, Windeyer MC.

J Am Vet Med Assoc. 2017 May 15;250(10):1167-1175. doi: 10.2460/javma.250.10.1167. No abstract available.

PMID:
28467749
9.

Status of the development of a vaccine against Mycoplasma bovis.

Perez-Casal J, Prysliak T, Maina T, Suleman M, Jimbo S.

Vaccine. 2017 May 19;35(22):2902-2907. doi: 10.1016/j.vaccine.2017.03.095. Epub 2017 Apr 19. Review.

PMID:
28433326
10.

Capsular polysaccharide from Mycoplasma mycoides subsp. mycoides shows potential for protection against contagious bovine pleuropneumonia.

Mwirigi M, Nkando I, Olum M, Attah-Poku S, Ochanda H, Berberov E, Potter A, Gerdts V, Perez-Casal J, Wesonga H, Soi R, Naessens J.

Vet Immunol Immunopathol. 2016 Oct 1;178:64-9. doi: 10.1016/j.vetimm.2016.07.002. Epub 2016 Jul 4.

PMID:
27496744
11.

Risk factors for Mycoplasma bovis-associated disease in farmed bison (Bison bison) herds in western Canada: A case-control study.

Bras AL, Barkema HW, Woodbury M, Ribble C, Perez-Casal J, Windeyer MC.

Prev Vet Med. 2016 Jul 1;129:67-73. doi: 10.1016/j.prevetmed.2016.05.011. Epub 2016 May 24.

PMID:
27317324
12.

Immune responses to Mycoplasma bovis proteins formulated with different adjuvants.

Prysliak T, Perez-Casal J.

Can J Microbiol. 2016 Jun;62(6):492-504. doi: 10.1139/cjm-2015-0762. Epub 2016 Feb 3.

PMID:
27105454
13.

Mycoplasma bovis isolates recovered from cattle and bison (Bison bison) show differential in vitro effects on PBMC proliferation, alveolar macrophage apoptosis and invasion of epithelial and immune cells.

Suleman M, Prysliak T, Clarke K, Burrage P, Windeyer C, Perez-Casal J.

Vet Microbiol. 2016 Apr 15;186:28-36. doi: 10.1016/j.vetmic.2016.02.016. Epub 2016 Feb 23.

PMID:
27016754
14.

Recombinant Mycoplasma mycoides proteins elicit protective immune responses against contagious bovine pleuropneumonia.

Nkando I, Perez-Casal J, Mwirigi M, Prysliak T, Townsend H, Berberov E, Kuria J, Mugambi J, Soi R, Liljander A, Jores J, Gerdts V, Potter A, Naessens J, Wesonga H.

Vet Immunol Immunopathol. 2016 Mar;171:103-14. doi: 10.1016/j.vetimm.2016.02.010. Epub 2016 Feb 23.

PMID:
26964722
15.

In vitro antimicrobial susceptibility of Mycoplasma bovis clinical isolates recovered from bison (Bison bison).

Suleman M, Prysliak T, Windeyer C, Perez-Casal J.

Can J Microbiol. 2016 Mar;62(3):272-8. doi: 10.1139/cjm-2015-0763. Epub 2015 Dec 18.

PMID:
26854525
16.

Experimental evaluation of inactivated and live attenuated vaccines against Mycoplasma mycoides subsp. mycoides.

Mwirigi M, Nkando I, Aye R, Soi R, Ochanda H, Berberov E, Potter A, Gerdts V, Perez-Casal J, Naessens J, Wesonga H.

Vet Immunol Immunopathol. 2016 Jan;169:63-7. doi: 10.1016/j.vetimm.2015.12.006. Epub 2015 Dec 17.

17.

Glyceradehyde-3-phosphate dehydrogenase as a suitable vaccine candidate for protection against bacterial and parasitic diseases.

Perez-Casal J, Potter AA.

Vaccine. 2016 Feb 17;34(8):1012-7. doi: 10.1016/j.vaccine.2015.11.072. Epub 2015 Dec 10. Review.

PMID:
26686572
18.

Analysis of immune responses to recombinant proteins from strains of Mycoplasma mycoides subsp. mycoides, the causative agent of contagious bovine pleuropneumonia.

Perez-Casal J, Prysliak T, Maina T, Wang Y, Townsend H, Berverov E, Nkando I, Wesonga H, Liljander A, Jores J, Naessens J, Gerdts V, Potter A.

Vet Immunol Immunopathol. 2015 Nov 15;168(1-2):103-10. doi: 10.1016/j.vetimm.2015.08.013. Epub 2015 Sep 9.

PMID:
26384697
19.

In vitro infection of bovine monocytes with Mycoplasma bovis delays apoptosis and suppresses production of gamma interferon and tumor necrosis factor alpha but not interleukin-10.

Mulongo M, Prysliak T, Scruten E, Napper S, Perez-Casal J.

Infect Immun. 2014 Jan;82(1):62-71. doi: 10.1128/IAI.00961-13. Epub 2013 Oct 14.

20.

Systemic mycoplasmosis with dystocia and abortion in a North American bison (Bison bison) herd.

Register KB, Woodbury MR, Davies JL, Trujillo JD, Perez-Casal J, Burrage PH, Clark EG, Windeyer MC.

J Vet Diagn Invest. 2013 Jul;25(4):541-5. doi: 10.1177/1040638713495029.

PMID:
23847228
21.
22.

Bactericidal activity of tracheal antimicrobial peptide against respiratory pathogens of cattle.

Taha-Abdelaziz K, Perez-Casal J, Schott C, Hsiao J, Attah-Poku S, Slavić D, Caswell JL.

Vet Immunol Immunopathol. 2013 Apr 15;152(3-4):289-94. doi: 10.1016/j.vetimm.2012.12.016. Epub 2013 Jan 4.

PMID:
23333196
23.

Vaccination with recombinant Mycoplasma bovis GAPDH results in a strong humoral immune response but does not protect feedlot cattle from an experimental challenge with M. bovis.

Prysliak T, van der Merwe J, Perez-Casal J.

Microb Pathog. 2013 Feb;55:1-8. doi: 10.1016/j.micpath.2012.12.001. Epub 2012 Dec 14.

PMID:
23246808
24.

Respiratory disease caused by Mycoplasma bovis is enhanced by exposure to bovine herpes virus 1 (BHV-1) but not to bovine viral diarrhea virus (BVDV) type 2.

Prysliak T, van der Merwe J, Lawman Z, Wilson D, Townsend H, van Drunen Littel-van den Hurk S, Perez-Casal J.

Can Vet J. 2011 Nov;52(11):1195-202.

25.

Role of GapC in the pathogenesis of Staphylococcus aureus.

Kerro-Dego O, Prysliak T, Perez-Casal J, Potter AA.

Vet Microbiol. 2012 May 4;156(3-4):443-7. doi: 10.1016/j.vetmic.2011.11.018. Epub 2011 Nov 28.

PMID:
22176759
26.

Protein chimeras containing the Mycoplasma bovis GAPDH protein and bovine host-defence peptides retain the properties of the individual components.

van der Merwe J, Prysliak T, Gerdts V, Perez-Casal J.

Microb Pathog. 2011 Jun;50(6):269-77. doi: 10.1016/j.micpath.2010.11.008. Epub 2011 Feb 3.

PMID:
21296650
27.

Invasion of bovine peripheral blood mononuclear cells and erythrocytes by Mycoplasma bovis.

van der Merwe J, Prysliak T, Perez-Casal J.

Infect Immun. 2010 Nov;78(11):4570-8. doi: 10.1128/IAI.00707-10. Epub 2010 Aug 16.

28.

Detection of antibodies against the Mycoplasma bovis glyceraldehyde-3-phosphate dehydrogenase protein in beef cattle.

Perez-Casal J, Prysliak T.

Microb Pathog. 2007 Nov-Dec;43(5-6):189-97. Epub 2007 May 29.

PMID:
17689221
29.

DNA-protein immunization against the GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus.

Kerro-Dego O, Prysliak T, Potter AA, Perez-Casal J.

Vet Immunol Immunopathol. 2006 Sep 15;113(1-2):125-38. Epub 2006 Jun 13.

PMID:
16777237
30.

Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis.

Perez-Casal J, Prysliak T, Kerro-Dego O, Potter AA.

Vet Immunol Immunopathol. 2006 Jan 15;109(1-2):85-97. Epub 2005 Sep 13.

PMID:
16165220
31.

Use of the surface proteins GapC and Mig of Streptococcus dysgalactiae as potential protective antigens against bovine mastitis.

Bolton A, Song XM, Willson P, Fontaine MC, Potter AA, Perez-Casal J.

Can J Microbiol. 2004 Jun;50(6):423-32.

PMID:
15284888
32.
33.
34.

Investigation of a novel DNase of Streptococcus suis serotype 2.

Fontaine MC, Perez-Casal J, Willson PJ.

Infect Immun. 2004 Feb;72(2):774-81.

35.

A GapC chimera retains the properties of the Streptococcus uberis wild-type GapC protein.

Perez-Casal J, Prysliak T, Potter AA.

Protein Expr Purif. 2004 Feb;33(2):288-96.

PMID:
14711517
36.

Characterization of a bovine lactoferrin binding protein of Streptococcus uberis.

Moshynskyy I, Jiang M, Fontaine MC, Perez-Casal J, Babiuk LA, Potter AA.

Microb Pathog. 2003 Nov;35(5):203-15.

PMID:
14521879
37.

Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2.

Lun S, Perez-Casal J, Connor W, Willson PJ.

Microb Pathog. 2003 Jan;34(1):27-37.

PMID:
12620382
38.

Bovine immunoglobulin A (IgA)-binding activities of the surface-expressed Mig protein of Streptococcus dysgalactiae.

Song XM, Perez-Casal J, Fontaine MC, Potter AA.

Microbiology. 2002 Jul;148(Pt 7):2055-64.

PMID:
12101294
39.

Changes in the leucocyte subpopulations of the palatine tonsillar crypt epithelium of pigs in response to Streptococcus suis type 2 infection.

Salles MW, Perez-Casal J, Willson P, Middleton DM.

Vet Immunol Immunopathol. 2002 Aug;87(1-2):51-63.

PMID:
12052342
40.

Immunisation of dairy cattle with recombinant Streptococcus uberis GapC or a chimeric CAMP antigen confers protection against heterologous bacterial challenge.

Fontaine MC, Perez-Casal J, Song XM, Shelford J, Willson PJ, Potter AA.

Vaccine. 2002 May 22;20(17-18):2278-86.

PMID:
12009283
41.

Surface-expressed mig protein protects Streptococcus dysgalactiae against phagocytosis by bovine neutrophils.

Song XM, Perez-Casal J, Bolton A, Potter AA.

Infect Immun. 2001 Oct;69(10):6030-7.

42.

A genetic locus involved in iron utilization unique to some Campylobacter strains.

Guerry P, Perez-Casal J, Yao R, McVeigh A, Trust TJ.

J Bacteriol. 1997 Jun;179(12):3997-4002.

43.

Role of the conserved C-repeat region of the M protein of Streptococcus pyogenes.

Perez-Casal J, Okada N, Caparon MG, Scott JR.

Mol Microbiol. 1995 Mar;15(5):907-16.

PMID:
7596292
44.
46.
47.
49.

Gene encoding the major subunit of CS1 pili of human enterotoxigenic Escherichia coli.

Perez-Casal J, Swartley JS, Scott JR.

Infect Immun. 1990 Nov;58(11):3594-600.

50.

Supplemental Content

Loading ...
Support Center